HOUSTON, TX, April 06, 2020 – Hope Biosciences, a clinical stage biotechnology company focused on developing cell-based therapeutics for acute and chronic di...

Partnering with Altoida, Inc. to Leverage Predictive Digital Biomarkers for Detection of Mild Cognitive Impairment due to Alzheimer’s Disease Hope Bioscience...

This year's Cellular Therapeutics in Trauma and Critical Care (CTTACC) conference is being held in San Diego from December 11-13. The two-and-a-half day conf...